Summit Therapeutics
National Account Director, Government Payers —Medicaid
Remote-Field (US) · Director
Stay score
odds of building a lasting career here
Thin sponsorship signal and lottery-bound. A low-probability bet with your clock running. Prioritize cap-exempt roles and proven entry-level sponsors first.
Lottery odds assume a STEM candidate.
Personalize to your clock →Employer immigration record
from this employer's Department of Labor filings
Files H-1B transfers
Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.
Community outcomes
No reports yet — be the first to help the next applicant.
About the role
- The National Accounts Director, Government Payers -Medicaid will be responsible for leadership and management of Fee-for-Service Medicaid, Managed Medicaid, and Medicaid Buying Pools and other assigned accounts.
- This is a critical customer-facing role helping to ensure broad access, reimbursement, and patient affordability.
Responsibilities
- Address physician-administered drug billing requirements at the state level, including NDC-to-HCPCS crosswalk requirements and state-specific claims mechanics that create access friction for buy-and-bill products.
Nice to have
- Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people.
- Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology.
- Summit has multiple global Phase 3 clinical studies, including:
- Non-small Cell Lung Cancer (NSCLC)
- Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
- Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
- Colorectal Cancer (CRC)
- Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Skills
- Bachelor's degree required; MBA, PharmD, or other advanced degree preferred.
- Minimum 10+ years of biopharmaceutical experience, with at least 5+ years in government payer, reimbursement, or policy roles.
- Minimum of 5+ years in Oncology or immuno-oncology account management experience.
- Demonstrated success in engaging with US Payers
- Strong understanding of the US healthcare payer/access landscape and regulatory environment
- Excellent strategic thinking, leadership, negotiation, and relationship management skills
- Exceptional communication and presentation skills
- Working knowledge of the Medicaid Drug Rebate Program, AMP/Best Price mechanics, and state Medicaid utilization management.
- Experience launching a buy-and-bill specialty or oncology product into the U.S. government payer channel.
- Ability to interpret regulation and translate it into commercial strategy for non-technical audiences.
- Successful record of achieving and maintaining compli
Benefits
- Establish and maintain relationships with key decisionmakers, including P&T, Medical and Pharmacy Director, and population-based stakeholders to secure appropriate access and optimal product positioning.
- Partner with HEOR and Medical Affairs to define the evidence government payers will require, including real-world evidence and economic analyses relevant to Medicaid populations, P&T, DUR Reviews.
- Assist Regional Sales teams with pull-or-sell through strategies based on payer coverage.
- Lead discussions with internal and external partners to ensure alignment on access, coverage, and reimbursement strategies.
Company info
- Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
This listing is sourced directly from Summit Therapeutics's careers page and normalized into a canonical job model.